Opus Genetics CEO George Magrath, MD, discusses how the company introduced virtual reality-enabled assessments and relied on digital endpoints to better measure participants’ vision changes.
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
The Significance Of Quality Data In Meeting FDA Regulatory Scrutiny
Data Science expert Rod McGlashing explains how scrutiny from the FDA spurs regulatory compliance, resulting in better data quality and the creation of optimal applications for intellectual property.
-
Better Data, Better Decisions
Learn how to achieve greater certainty in clinical trial financial management by leveraging adaptive, accurate, and defendable fair market value.
-
The Benefits Of Real-Time ePRO/eCOA In Clinical Trials
TrialKit addresses data management issues in clinical trials through its innovative ePRO and eCOA tools, which facilitate real-time data collection and reporting.
-
Everest Group Life Sciences EDC Products PEAK Matrix® Assessment 2024
This Everest Group report examines Medidata’s Rave EDC and its impact on the clinical development value chain of life sciences.
-
Simplifying The Regulatory Submission Process With A Modern CTMS
Working in collaboration with industry representatives, explore the value that pulling the regulatory submission process into a modern Clinical Trial Management System (CTMS) could have.
-
Increase Participant Diversity With eClinical Tools
The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.
-
Clinical Trial Logistics: Meeting Unique Participant Needs
Uncover why delivering a comprehensive service entails establishing a robust global network equipped with the expertise, resources, and adaptability to address diverse participant needs worldwide.
-
Configurability And Customization: Key Features In An eTMF Solution
Discover how a configurable and customizable eTMF can lend itself to better information control during a clinical trial while boosting security and regulatory compliance efforts.
-
Timely Lab Data To Inform Outreach To Healthcare Professionals
Learn how you can leverage a system that offers flexible data delivery formats and seamless integration into commercialization workflows while also ensuring HIPAA-compliant deidentified data for patient privacy.
-
Digital Medicine Society Accelerates Recruitment and Results With eConsent
Find out how the Digital Medicine Society (DiMe), an interdisciplinary professional society for digital medicine, was able to deploy an eConsent module in less than two weeks to support its remote study to assess nocturnal scratching as an endpoint for patients.